{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:07:45Z","timestamp":1781140065347,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001502","name":"Dae Hwa Pharmaceuticals Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ijpharm.2018.10.044","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:57:01Z","timestamp":1540007821000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid\/saccharin for improvement of wettability and dissolution rate"],"prefix":"10.1016","volume":"554","author":[{"given":"Sang-Min","family":"Hyun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif Md","family":"Abuzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soohun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yechan","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyeon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitaram","family":"Velaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-3822","authenticated-orcid":false,"given":"Sung-Joo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.10.044_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.12.041","article-title":"Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process","volume":"538","author":"Abuzar","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0928-0987(03)00201-X","article-title":"Characterization of solid-state forms of celecoxib","volume":"20","author":"Chawla","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0015","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40005-012-0023-6","article-title":"Development of cataplasmic transdermal drug delivery system containing eutectic mixture of lidocaine and prilocaine","volume":"42","author":"Chun","year":"2012","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2012.11.031","article-title":"Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model","volume":"441","author":"Dong","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijpharm.2015.03.045","article-title":"In-situ synchrotron wide-angle X-ray diffraction as a rapid method for cocrystal\/salt screening","volume":"496","author":"Dong","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejphar.2004.11.036","article-title":"The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats","volume":"507","author":"El-Medany","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0035","series-title":"Drug Mixture with Enhanced Dissolution Rate","first-page":"40","author":"Ewing","year":"2003"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2017.04.021","article-title":"Enhancement of dissolution rate through eutectic mixture and solid solution of posaconazole and benznidazole","volume":"525","author":"Figueiredo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0045","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1039\/B613073A","article-title":"Exploring cocrystal \u2013 cocrystal reactivity via liquid-assisted grinding: the assembling of racemic and dismantling of enantiomeric cocrystals","author":"Friscic","year":"2006","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0050","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11167-005-0305-0","article-title":"Solubility of adipic acid in organic solvents and water","volume":"78","author":"Gaivoronskii","year":"2005","journal-title":"Russ. J. Appl. Chem."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejps.2009.04.005","article-title":"Correlating thermodynamic and kinetic parameters with amorphous stability","volume":"37","author":"Graeser","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2007.11.045","article-title":"Development of a rapidly dispersing tablet of a poorly wettable compound \u2013 formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib","volume":"353","author":"He","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(00)00426-9","article-title":"Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC","volume":"202","author":"Ishikawa","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0070","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2011.01.012","article-title":"Targeting apoptosis pathways by Celecoxib in cancer","volume":"332","author":"Jendrossek","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2012.02.037","article-title":"Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib","volume":"428","author":"Kang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0080","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1248\/cpb.9.866","article-title":"Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man","volume":"9","author":"Keiji","year":"1961","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1248\/cpb.12.134","article-title":"Studies on absorption of eutectic mixture. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits","volume":"12","author":"Keiji","year":"1964","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40005-013-0057-4","article-title":"Antitumor effect of a newly synthesized celecoxib derivative encapsulated in liposome","volume":"43","author":"Kim","year":"2013","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0095","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1248\/cpb.58.230","article-title":"Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives","volume":"58","author":"Kim","year":"2010","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2004.03.033","article-title":"Shear distribution and variability in the USP Apparatus 2 under turbulent conditions","volume":"279","author":"Kukura","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijpharm.2016.08.034","article-title":"Enhanced oral delivery of celecoxib via the development of a supersaturable amorphous formulation utilising mesoporous silica and co-loaded HPMCAS","volume":"512","author":"Laine","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0001-8686(01)00080-X","article-title":"Study of the advancing and receding contact angles: liquid sorption as a cause of contact angle hysteresis","volume":"96","author":"Lam","year":"2002","journal-title":"Adv. Colloid Interface"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0115","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jps.2600661034","article-title":"Contact angles of pharmaceutical powders","volume":"66","author":"Lerk","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jps.2600650611","article-title":"Contact angles and wetting of pharmaceutical powders","volume":"65","author":"Lerk","year":"1976","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2014.02.004","article-title":"Understanding the relationship between wettability and dissolution of solid dispersion","volume":"465","author":"Lu","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/s40005-018-0393-5","article-title":"Modified sprouted rice for modulation of curcumin crystallinity and dissolution enhancement by solid dispersion","author":"Luu","year":"2018","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tca.2007.11.022","article-title":"Phase transitions in amorphous calcium phosphates with different Ca\/P ratios","volume":"468","author":"Maciejewski","year":"2008","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0145","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1039\/C8CE00859K","article-title":"Cocrystal formation by ionic liquid-assisted grinding: case study with cocrystals of caffeine","volume":"20","author":"Mukherjee","year":"2018","journal-title":"CrystEngComm"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jps.20296","article-title":"Water adsorption kinetics and contact angles of pharmaceutical powders","volume":"94","author":"Muster","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40005-012-0021-8","article-title":"Preparation and in vivo evaluation of immediate-release pellet containing celecoxib solid dispersion","volume":"42","author":"Park","year":"2012","journal-title":"J. Pharm. Invest."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0160","series-title":"Eutectic Mixture Comprising Celecoxib and Poloxamer","first-page":"9","author":"Park","year":"2013"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3565(24)29580-X","article-title":"Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption","volume":"297","author":"Paulson","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijpharm.2011.06.013","article-title":"Chemical and in vitro enzymatic stability of newly synthesized celecoxib lipophilic and hydrophilic amides","volume":"416","author":"Qandil","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.etp.2006.06.004","article-title":"Effects of cyclooxygenase inhibition on the gastrointestinal tract","volume":"58","author":"Radi","year":"2006","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2018.01.039","article-title":"Stable and sustained release liposomal formulations of celecoxib: in vitro and in vivo anti-tumor evaluation","volume":"540","author":"Riahi","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0185","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/mp100114a","article-title":"Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption","volume":"7","author":"Shi","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0190","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0195","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jps.20287","article-title":"Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state","volume":"94","author":"Sinha","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0200","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0205","doi-asserted-by":"crossref","first-page":"14833","DOI":"10.3390\/molecules200814833","article-title":"Non-covalent derivatives: cocrystals and eutectics","volume":"20","author":"Stoler","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0210","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1248\/bpb.27.1993","article-title":"Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib","volume":"27","author":"Subramanian","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/zaac.19030370121","article-title":"\u00dcber die Ermittelung der Zusammensetzung chemischer Verbindungen ohne Hilfe der Analyse","volume":"37","author":"Tammann","year":"1903","journal-title":"Zeitschrift f\u00fcr anorganische Chemie"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0220","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.05.048","article-title":"Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer","volume":"453","author":"Tomaszewska","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14227\/DT210214P24","article-title":"Determination of intrinsic dissolution rate using miniaturized rotating and stationary disk systems","volume":"21","author":"Tseng","year":"2014","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0230","unstructured":"USP, 2012. 1087-Apparent Intrinsic Dissolution-Dissolution Testing Procedures for Rotating Disk and Stationary Disk. In The United States Pharmacopeia and National Formulary USP 35\u2013NF 30, pp. 660\u2013663."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1096\/fasebj.1.2.3111928","article-title":"Inflammation and the mechanism of action of anti-inflammatory drugs","volume":"1","author":"Vane","year":"1987","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0240","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.drudis.2007.09.005","article-title":"Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs","volume":"12","author":"Vasconcelos","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0245","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2006.02.006","article-title":"Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin","volume":"314","author":"Ventura","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0250","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","article-title":"Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis","volume":"96","author":"Warner","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2018.05.041","article-title":"Pharmaceutical-grade oral films as substrates for printed medicine","volume":"547","author":"Wimmer-Teubenbacher","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0010-7824(88)90112-6","article-title":"Norethisterone-cholesterol eutectic mixture as an oral sustained-release hormonal preparation: bioequivalence study in humans","volume":"37","author":"Yanez","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejps.2004.08.008","article-title":"Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol","volume":"23","author":"Yong","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2003.10.016","article-title":"Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs","volume":"270","author":"Yu","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.10.044_b0275","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ijpharm.2018.10.044_b0280","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jps.2600650805","article-title":"Wettability of pharmaceutical solids: estimates of solid surface polarity","volume":"65","author":"Zografi","year":"1976","journal-title":"J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318307841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318307841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:55:26Z","timestamp":1775249726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318307841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":56,"alternative-id":["S0378517318307841"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.10.044","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid\/saccharin for improvement of wettability and dissolution rate","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}